AntriaBio, Inc. Stock Price - ANTB

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Antriabio, Inc. (QB) ANTB Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.06 +5.26% 1.2 1.2 1.15 1.15 1.14 16:00:05
Bid Price Ask Price Spread Spread % News
1.03 1.2 0.17 14.17% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4 811 $ 1.1562 $ 937.649815 5.98k 0.63 - 2.00
Last Trade Time Type Quantity Stock Price Currency
11:12:07 100 $1.20 USD

Antriabio, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 61.19M 50.99M $ -14.94M - -4.10 29.99M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.75k 0.01% $ - 0.00% - -

more financials information »

Antriabio, Inc. (QB) News

Latest ANTB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ANTB Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.
1 Month1.
3 Months1.11.2510.0000055k6k0.19.09%
6 Months0.871.250.820.0000066k8k0.3337.93%
1 Year120.6250.0000098k9k0.220.00%
3 Years1.522.250.6250.00000182k7k-0.32-21.05%
5 Years0.6540.20.00000182k8k0.5584.62%

Antriabio, Inc. (QB) Description

AntriaBio is a biopharmaceutical company that develops novel extended release therapies by combining proprietary formulation and manufacturing capabilities with well-known molecules to significantly improve standards of care. AntriaBio's lead product candidate is AB101, an injectable once-weekly basal insulin for type 1 and type 2 diabetes that addresses a $11 billion market where the current standard of care is a once-daily basal insulin injection.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.